2mzz
From Proteopedia
(Difference between revisions)
(7 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==NMR structure of APOBEC3G NTD variant, sNTD== | |
+ | <StructureSection load='2mzz' size='340' side='right'caption='[[2mzz]]' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[2mzz]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MZZ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2MZZ FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2mzz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mzz OCA], [https://pdbe.org/2mzz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2mzz RCSB], [https://www.ebi.ac.uk/pdbsum/2mzz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2mzz ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The human APOBEC3G (A3G) DNA cytosine deaminase restricts and hypermutates DNA-based parasites including HIV-1. The viral infectivity factor (Vif) prevents restriction by triggering A3G degradation. Although the structure of the A3G catalytic domain is known, the structure of the N-terminal Vif-binding domain has proven more elusive. Here, we used evolution- and structure-guided mutagenesis to solubilize the Vif-binding domain of A3G, thus permitting structural determination by NMR spectroscopy. A smaller zinc-coordinating pocket and altered helical packing distinguish the structure from previous catalytic-domain structures and help to explain the reported inactivity of this domain. This soluble A3G N-terminal domain is bound by Vif; this enabled mutagenesis and biochemical experiments, which identified a unique Vif-interacting surface formed by the alpha1-beta1, beta2-alpha2 and beta4-alpha4 loops. This structure sheds new light on the Vif-A3G interaction and provides critical information for future drug development. | ||
- | + | Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.,Kouno T, Luengas EM, Shigematsu M, Shandilya SM, Zhang J, Chen L, Hara M, Schiffer CA, Harris RS, Matsuo H Nat Struct Mol Biol. 2015 May 18. doi: 10.1038/nsmb.3033. PMID:25984970<ref>PMID:25984970</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
- | [[Category: | + | <div class="pdbe-citations 2mzz" style="background-color:#fffaf0;"></div> |
- | [[Category: | + | == References == |
- | [[Category: | + | <references/> |
- | [[Category: | + | __TOC__ |
- | [[Category: | + | </StructureSection> |
- | [[Category: Luengas | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Synthetic construct]] |
- | [[Category: Shandilya | + | [[Category: Chen L]] |
- | [[Category: | + | [[Category: Hara M]] |
- | [[Category: | + | [[Category: Harris RS]] |
+ | [[Category: Kouno T]] | ||
+ | [[Category: Luengas EM]] | ||
+ | [[Category: Matsuo H]] | ||
+ | [[Category: Schiffer CA]] | ||
+ | [[Category: Shandilya SMD]] | ||
+ | [[Category: Shigematu M]] | ||
+ | [[Category: Zhang J]] |
Current revision
NMR structure of APOBEC3G NTD variant, sNTD
|
Categories: Large Structures | Synthetic construct | Chen L | Hara M | Harris RS | Kouno T | Luengas EM | Matsuo H | Schiffer CA | Shandilya SMD | Shigematu M | Zhang J